Akouos IPO Presentation Deck

Experienced Management Team with Otology, Genetic Medicine, and Rare Disease Drug Development Expertise 6 Emmanuel Simons, Ph.D., M.B.A. Founder, Chief Executive Officer Rabia Gurses Ozden, M.D. Chief Development Officer Morgan Molloy Chief Corporate Development Officer Jennifer Wellman SVP, Regulatory & Quality AM PIVOTAL Voyager nightstar &agtc gsk Spark genzyme Biogen Spark of Philadelphi AVIGEN Broad Base of Top Tier Investors EcoR1 CAPITAL COWEN HEALTHCARE INVESTMENTS RACAPITAL CONFIDENTIAL Michael McKenna, M.D. Founder, Chief Medical Officer Gregory Robinson, Ph.D. Chief Scientific Officer Karoline Shair, Ph.D., J.D. General Counsel John Connelly SVP, Portfolio Strategy, R&D Operations Fidelity SOFINNOVA NEA SURVEYOR AKOUOS HARVARD nightstar agilis Shire Biogen Takeda VA Voyager genzyme

View entire presentation